TY - JOUR
T1 - Interferon-γ directly inhibits TRANCE-induced osteoclastogenesis
AU - Fox, S.W.
AU - Chambers, T.J.
PY - 2000/10/5
Y1 - 2000/10/5
N2 - The immune system has profound effects on bone remodeling. IFN-γ, a major product of immune cells, potently inhibits bone resorption, but its mechanism of action is unknown. We found in cultures of stroma-free mononuclear precursors that IFN-γ strongly suppresses TRANCE/RANKL-induced osteoclast formation in a dose-dependent manner. This direct effect on osteoclast progenitors was not due to stimulation of NO production by IFN-γ, as the NOS inhibitors 1400W and L-NAME were unable to reverse the suppression. However, TGFβ1, which has opposing actions to IFN-γ on diverse cellular functions, was able to antagonize the effect of IFN-γ. This suggests that IFN-γ prevents osteoclast formation by actively directing the differentiation of osteoclastic progenitors toward an alternative cytocidal lineage to the osteoclast.
AB - The immune system has profound effects on bone remodeling. IFN-γ, a major product of immune cells, potently inhibits bone resorption, but its mechanism of action is unknown. We found in cultures of stroma-free mononuclear precursors that IFN-γ strongly suppresses TRANCE/RANKL-induced osteoclast formation in a dose-dependent manner. This direct effect on osteoclast progenitors was not due to stimulation of NO production by IFN-γ, as the NOS inhibitors 1400W and L-NAME were unable to reverse the suppression. However, TGFβ1, which has opposing actions to IFN-γ on diverse cellular functions, was able to antagonize the effect of IFN-γ. This suggests that IFN-γ prevents osteoclast formation by actively directing the differentiation of osteoclastic progenitors toward an alternative cytocidal lineage to the osteoclast.
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-0034610060&partnerID=MN8TOARS
U2 - 10.1006/bbrc.2000.3577
DO - 10.1006/bbrc.2000.3577
M3 - Article
SN - 0006-291X
VL - 276
SP - 868
EP - 872
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -